SFBC at buy by Jefferies

Jefferies & Co., Inc. analyst David Windley rated SFBC International, Inc. at buy after the company announced it is ceasing its Florida operations. The Miami-Dade County Unsafe Structures Board did not extend its review of the company's remediation plans, limiting its ability to conduct studies in the Miami facility. Shares of the Princeton, N.J., drug development services company were up 46 cents, or 2.88%, at $16.41 on volume of 1,301,592 shares versus the three-month running average of 886,500 shares. (Nasdaq: SFCC)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.